Home/Filings/4/0001437749-20-008574
4//SEC Filing

NOVIT, L.P. 4

Accession 0001437749-20-008574

CIK 0000922247other

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 4:05 PM ET

Size

7.5 KB

Accession

0001437749-20-008574

Insider Transaction Report

Form 4
Period: 2020-04-24
Transactions
  • Purchase

    Common Stock

    2020-04-24$0.10/sh+2,000,000$200,00011,517,582 total
Transactions
  • Purchase

    Common Stock

    2020-04-24$0.10/sh+2,000,000$200,00011,517,582 total
NOVIT, L.P.
10% Owner
Transactions
  • Purchase

    Common Stock

    2020-04-24$0.10/sh+2,000,000$200,00011,517,582 total
Footnotes (1)
  • [F1]Represents securities directly owned by Novit, L.P. ("Novit"). Each of the other Reporting Persons are indirect beneficial owners of such securities as follows: Novit U.S., Inc. is the general partner of Novit, and Katarzyna Kusmierz is the trustee of the NAP Trust, which indirectly owns all of the outstanding partnership interests in Novit.

Issuer

Cyclo Therapeutics, Inc.

CIK 0000922247

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001606624

Filing Metadata

Form type
4
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:05 PM ET
Size
7.5 KB